Noninvasive assessment of reperfusion therapy: slow progress towards a worthwhile goal.
James A
JA
de Lemos
David A
DA
Morrow
D001145:Arrhythmias, Cardiac / Q000097:blood / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control*; D015415:Biomarkers / Q000097:blood; D003402:Creatine Kinase / Q000097:blood; D004562:Electrocardiography; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D015425:Myocardial Reperfusion / Q000009:adverse effects / Q000379:methods*; D009211:Myoglobin / Q000097:blood; D014654:Vascular Patency
D015415:Biomarkers; D005343:Fibrinolytic Agents; D009211:Myoglobin; D003402:Creatine Kinase